SATE (aryl) phosphotriester series. II. Stability studies and physicochemical parameters

Area of Science:

• Medicinal Chemistry
• Nucleoside Analog Chemistry
• Drug Delivery Systems

Background:

• 3'-azido-2',3'-dideoxythymidine (AZT) is a key antiviral nucleoside analog.
• Prodrug strategies are essential for improving the intracellular delivery and efficacy of nucleoside analogs.
• Phosphotriester derivatives offer a potential route for enhanced prodrug design.

Purpose of the Study:

• To evaluate the stability and intracellular delivery of novel phosphotriester derivatives of AZT.
• To investigate the role of S-pivaloyl-2-thioethyl (tBuSATE) and L-tyrosine-derived aryl groups in prodrug performance.
• To elucidate the hydrolytic mechanisms responsible for the release of the active mononucleotide.

Main Methods:

• Synthesis of phosphotriester derivatives incorporating tBuSATE and aryl moieties.
• Incubation of compounds in various biological media (e.g., plasma, cell lysates).
• Analysis of compound stability and metabolite formation using HPLC and mass spectrometry.
• Assessment of intracellular delivery and activation in relevant cell models.

Main Results:

• The evaluated phosphotriester derivatives exhibited significant stability in biological media.
• Successful intracellular delivery of the parent AZT mononucleotide was confirmed.
• Hydrolysis proceeded sequentially via esterase and phosphodiesterase enzymatic activities.
• The nature of the aryl residue influenced the hydrolysis rates and overall delivery efficiency.

Conclusions:

• Phosphotriester derivatives of AZT, functionalized with tBuSATE and specific aryl groups, represent effective prodrugs.
• These prodrugs facilitate efficient intracellular delivery of AZT mononucleotide through sequential enzymatic cleavage.
• The findings support the potential of this prodrug strategy for enhancing AZT's therapeutic applications.